CloudCath PD System Wins U.S. FDA Clearance

A new device that scans used PD fluid in real-time can be set up in seconds to alert care teams to possible peritonitis, reduce hospital stays, and prolong time on PD. Next step: a limited launch in targeted areas.

Read the full article » | Posted 03-16-2022

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026